IRIS
BARBANTI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.037
AS - Asia 11.849
EU - Europa 8.829
SA - Sud America 1.762
AF - Africa 147
OC - Oceania 16
Totale 37.640
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.819
HK - Hong Kong 7.923
IE - Irlanda 5.958
SG - Singapore 2.197
BR - Brasile 1.448
GB - Regno Unito 938
IT - Italia 476
CN - Cina 453
CH - Svizzera 413
VN - Vietnam 395
FI - Finlandia 331
DE - Germania 241
BD - Bangladesh 236
TR - Turchia 159
AR - Argentina 123
IN - India 110
FR - Francia 100
CA - Canada 93
MX - Messico 83
EC - Ecuador 53
NL - Olanda 53
IQ - Iraq 52
PL - Polonia 50
CO - Colombia 46
EE - Estonia 41
ID - Indonesia 41
RU - Federazione Russa 38
ZA - Sudafrica 38
CZ - Repubblica Ceca 36
UZ - Uzbekistan 33
PK - Pakistan 31
KR - Corea 28
ES - Italia 26
MA - Marocco 25
AT - Austria 24
JP - Giappone 24
SE - Svezia 24
PY - Paraguay 23
PH - Filippine 20
EG - Egitto 19
UA - Ucraina 19
VE - Venezuela 19
CL - Cile 18
UY - Uruguay 18
KE - Kenya 17
SA - Arabia Saudita 15
AU - Australia 14
MY - Malesia 13
IL - Israele 11
IR - Iran 11
JO - Giordania 11
AE - Emirati Arabi Uniti 10
ET - Etiopia 10
NP - Nepal 10
PE - Perù 10
TN - Tunisia 10
AZ - Azerbaigian 9
BG - Bulgaria 8
DZ - Algeria 8
TH - Thailandia 8
TW - Taiwan 8
CR - Costa Rica 7
JM - Giamaica 7
LT - Lituania 7
KZ - Kazakistan 6
LV - Lettonia 6
HN - Honduras 5
LY - Libia 5
OM - Oman 5
TT - Trinidad e Tobago 5
AM - Armenia 4
AO - Angola 4
BE - Belgio 4
BH - Bahrain 4
BO - Bolivia 4
BY - Bielorussia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GR - Grecia 4
KG - Kirghizistan 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BB - Barbados 3
CY - Cipro 3
HU - Ungheria 3
MD - Moldavia 3
NI - Nicaragua 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
TG - Togo 3
UG - Uganda 3
KH - Cambogia 2
LB - Libano 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
CV - Capo Verde 1
GD - Grenada 1
GE - Georgia 1
Totale 37.622
Salva come PNG Salva come JPEG
Città #
Hong Kong 7.922
Dallas 6.302
Dublin 5.920
Ashburn 1.580
San Jose 1.567
Singapore 1.062
London 835
Boardman 807
The Dalles 481
Chicago 473
Santa Clara 455
Zurich 406
Helsinki 318
Washington 197
Ho Chi Minh City 138
Los Angeles 128
São Paulo 127
Istanbul 115
Beijing 92
Hanoi 87
New York 87
Assago 76
Munich 73
Rio de Janeiro 54
Council Bluffs 51
Milan 51
Rome 44
Warsaw 43
Hillsboro 42
San Francisco 42
Belo Horizonte 38
Orem 36
Frankfurt am Main 35
Montreal 33
Mexico City 31
Seattle 29
Amsterdam 28
Tashkent 28
Brooklyn 27
Chennai 27
Brasília 26
Seoul 25
Catania 24
Porto Alegre 22
Brno 21
Guayaquil 21
Salvador 20
Atlanta 18
Johannesburg 18
Stockholm 18
Curitiba 17
Manchester 17
Montevideo 17
Boston 16
Da Nang 16
Haiphong 16
Nairobi 16
Quito 16
Buffalo 15
Hải Dương 15
Mumbai 15
Naples 15
Shanghai 15
Campinas 14
Olomouc 14
Tokyo 14
Falkenstein 13
Buenos Aires 12
Dhaka 12
Duque de Caxias 12
Goiânia 12
Guarulhos 12
Thái Bình 12
Amman 11
Baghdad 11
Fortaleza 11
Phoenix 11
Toronto 11
Cipolletti 10
Genoa 10
Reston 10
Ribeirão Preto 10
Thái Nguyên 10
Turku 10
Addis Ababa 9
Bexley 9
Casablanca 9
Clifton 9
Düsseldorf 9
Erbil 9
Guangzhou 9
Jeddah 9
Karachi 9
Lahore 9
Medellín 9
Piscataway 9
Turin 9
Baku 8
Cairo 8
Caracas 8
Totale 30.689
Salva come PNG Salva come JPEG
Nome #
1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study 2.466
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease 1.179
Prosthesis choice for transcatheter aortic valve replacement: Improved outcomes with the adoption of a patient-specific transcatheter heart valve selection algorithm 973
Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis 969
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 722
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry 655
Medical Comorbidities in Alzheimer's Disease: An Autopsy Confirmed Study with a Focus on Sex-Differences? 581
Embolic protection device in a patient with large left ventricular thrombus undergoing transcatheter aortic valve replacement 567
Predicting neocommissural orientation during TAVI workup 510
Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison 496
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement 444
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 391
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 380
Le nuove frontiere della cardiologia interventistica strutturale 358
Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study 147
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 141
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 140
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 138
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 132
Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project 132
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 130
[Transcatheter aortic valve implantation: are we ready? If so, for which patients? Is it sustainable? The interventional cardiologist's point of view] 127
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 126
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? 123
Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes 123
Transcatheter mitral valve implantation: CardiAQ 122
A minimalistic approach for transfemoral transcatheter aortic valve implantation therapy: a prospective “real-world” study 115
Late Degeneration of Transcatheter Aortic Valves: Pathogenesis and Management 115
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry 115
Accuracy of intracardiac echocardiography for aortic root assessment in patients undergoing transcatheter aortic valve implantation 112
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation 111
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis 108
Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey 108
5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis 108
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 107
5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction 106
Transcatheter aortic valve-in-valve implantation to treat aortic para-valvular regurgitation after TAVI 106
ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases 103
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry 103
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 102
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration 101
[Evolution of transcatheter aortic valve implantation from a high-volume Italian center: report of 2058 procedures over 15-year experience] 100
Managing complications after transcatheter aortic valve implantation 99
Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry 98
Acute left atrial spontaneous echocardiographic contrast and suspicious thrombus formation following mitral regurgitation reduction with the MitraClip system 98
Early detection of transcatheter heart valve dysfunction 97
Transcatheter Mitral Valve Implantation: CardiAQ-Edwards 97
CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry 96
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 96
Functional and metabolic frailty predicts mortality in patients undergoing TAVI: Insights from the OBSERVANT II study 96
Acute and long-term (2-years) clinical outcomes of the CoreValve 31mm in large aortic annuli: A multicenter study 96
[First results from the OBSERVANT II study: clinical characteristics of patients with aortic stenosis undergoing transcatheter treatment with new generation devices] 96
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 94
Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation 94
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation 93
Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement 92
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry 92
Early and late outcomes after transcatheter versus surgical aortic valve replacement in obese patients 92
A gender based analysis of predictors of all cause death after transcatheter aortic valve implantation 91
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 90
One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry) 90
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 90
Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve 89
Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device 89
Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis 88
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 88
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 88
Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation 87
Early and mid-term outcome of patients with low-flow-low-gradient aortic stenosis treated with newer-generation transcatheter aortic valves 87
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement 87
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5 86
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 86
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry 86
Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection 86
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis 85
The Helio transcatheter aortic dock for patients with aortic regurgitation 85
Cerebral embolization during transcatheter aortic valve implantation 85
Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation 85
Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention 85
Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry 85
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation 84
Bioprosthetic valves for transcatheter aortic valve replacement 84
OBSERVANT II: OBservational Study of Effectiveness of transcatheter aortic valve implantation with new geneRation deVices for severe Aortic steNosis Treatment. Study protocol 84
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 83
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death 83
Real-World Multiple Comparison of Transcatheter Aortic Valves: Insights From the Multicenter OBSERVANT II Study 83
Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort 83
Transcatheter Aortic Valve Replacement With Intra-Annular Self-Expanding or Balloon-Expandable Valves 83
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia 82
Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry 82
Management of severe stenosis controversies and promises 82
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study 82
Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management 82
Pacemaker dependency after transcatheter aortic valve implantation: incidence, predictors and long-term outcomes 82
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 81
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry 81
Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis 81
One-Year Outcomes after Surgical versus Transcatheter Aortic Valve Replacement with Newer Generation Devices 81
Severe aortic valve stenosis: Symptoms, biochemical markers, and global longitudinal strain 81
Early Discharge After Transcatheter Aortic Valve Replacement: Mature Times 81
Totale 19.081
Salva come PNG Salva come JPEG
Categoria #
all - tutte 168.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.712
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231.386 0 0 0 0 0 0 0 0 0 269 817 300
2023/20247.574 278 707 401 540 1.311 1.170 1.228 492 439 431 249 328
2024/202514.265 1.491 249 544 152 610 681 7.367 307 978 692 766 428
2025/202614.896 870 3.391 3.663 1.212 323 469 1.512 975 991 848 420 222
Totale 38.121